AC Immune SA

NASDAQ:ACIU   3:59:44 PM EDT
6.34
+0.31 (+5.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)478.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.19 Million
Adjusted EPS-$0.29
See more estimates
10-Day MA$6.07
50-Day MA$5.46
200-Day MA$6.45
See more pivots

AC Immune SA Stock, NASDAQ:ACIU

EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, SWITZERLAND 00000
Switzerland
Phone: 41 21 345 91 21
Number of Employees: 67

Description

AC Immune SA is a biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases.